MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

PDL BioPharma Company Profile (NASDAQ:PDLI)

Consensus Ratings for PDL BioPharma (NASDAQ:PDLI) (?)
Ratings Breakdown: 2 Hold Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $4.00 (30.29% upside)

Analysts' Ratings History for PDL BioPharma (NASDAQ:PDLI)
Show:
DateFirmActionRatingPrice TargetActions
4/17/2016Cowen and CompanyReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/23/2016RBC CapitalLower Price TargetSector Perform$5.00 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/24/2014 forward)
Earnings History for PDL BioPharma (NASDAQ:PDLI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/3/2016        
5/4/2016Q116$0.50$0.52$142.05 million$103.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/22/2016Q415$0.54$0.61$149.20 million$178.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2015Q315$0.61$0.42$164.80 million$124.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2015Q215$0.52$0.47$137.75 million$138.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2015Q115$0.52$0.50$140.80 million$149.71 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/23/2015Q414$0.57$0.32$158.15 million$117.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/10/2014Q314$0.56$0.61$165.10 million$164.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/18/2014Q214$0.46$0.52$134.07 million$162.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/12/2014Q114$0.45$0.44$130.93 million$139.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/3/2014Q413$0.43$0.39$115.22 million$110.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2013Q313$0.37$0.36$97.09 million$97.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/8/2013Q2 2013$0.54$0.62$138.20 million$143.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2013Q1 2013$0.35$0.36$91.69 million$91.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/1/2013Q4 2012$0.31$0.34$86.08 million$86.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2012Q312$0.33$0.32$85.03 million$85.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2012$0.44$0.52ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2012$0.27$0.29ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/23/2012$0.28$0.24ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/9/2011$0.27$0.28ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/27/2011$0.39$0.39ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/27/2011$0.24$0.25ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/28/2011$0.21$0.20ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for PDL BioPharma (NASDAQ:PDLI)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for PDL BioPharma (NASDAQ:PDLI)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
5/4/2016quarterly$0.056.25%6/2/20166/6/20166/13/2016Tweet This Announcement  Share This Announcement on StockTwits
2/1/2016quarterly$0.057.27%3/2/20163/4/20163/11/2016Tweet This Announcement  Share This Announcement on StockTwits
2/2/2015quarterly$0.158.22%9/2/20169/4/20169/11/2016Tweet This Announcement  Share This Announcement on StockTwits
2/2/2015quarterly$0.158.22%6/1/20166/5/20166/12/2016Tweet This Announcement  Share This Announcement on StockTwits
1/30/2015quarterly$0.158.23%6/3/20156/5/20156/12/2015Tweet This Announcement  Share This Announcement on StockTwits
1/30/2015quarterly$0.158.23%3/3/20153/5/20153/12/2015Tweet This Announcement  Share This Announcement on StockTwits
1/30/2015quarterly$0.158.23%12/2/201512/4/201512/11/2015Tweet This Announcement  Share This Announcement on StockTwits
1/30/2015quarterly$0.158.23%9/2/20159/4/20159/11/2015Tweet This Announcement  Share This Announcement on StockTwits
1/31/2014quarterly$0.156.59%9/3/20149/5/20149/12/2014Tweet This Announcement  Share This Announcement on StockTwits
1/31/2014quarterly$0.156.59%3/3/20143/5/20143/12/2014Tweet This Announcement  Share This Announcement on StockTwits
1/31/2014quarterly$0.156.59%12/3/201412/5/201412/12/2014Tweet This Announcement  Share This Announcement on StockTwits
1/31/2014quarterly$0.156.59%6/3/20146/5/20146/12/2014Tweet This Announcement  Share This Announcement on StockTwits
1/31/2013quarterly$0.158.72%12/3/201312/5/201312/12/2013Tweet This Announcement  Share This Announcement on StockTwits
1/31/2013quarterly$0.158.72%6/3/20136/5/20136/12/2013Tweet This Announcement  Share This Announcement on StockTwits
1/31/2013quarterly$0.158.72%9/3/20139/5/20139/12/2013Tweet This Announcement  Share This Announcement on StockTwits
1/30/2013quarterly$0.158.72%3/1/20133/5/20133/12/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)
Insider Trading History for PDL BioPharma (NASDAQ:PDLI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
12/15/2015Peter S. GarciaCFOBuy5,000$3.64$18,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/14/2015Peter S. GarciaCFOBuy10,000$3.42$34,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/7/2015Steffen PietzkeCAOBuy20,590$3.64$74,947.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2015Peter S GarciaCFOBuy20,000$5.83$116,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2014Harold E SelickDirectorBuy6,000$8.08$48,480.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for PDL BioPharma (NASDAQ:PDLI)
DateHeadline
06/24/16 08:22 AMPDL BioPharma, Inc. (NASDAQ:PDLI) Quarterly Dividend Payout At $-8.233 Millions - Stocks Daily
06/21/16 10:09 AMPDL BioPharma Inc(NASDAQ:PDLI) Declares Dividend of $0.0500. - TheFounders Daily
06/20/16 02:41 PMPDL BioPharma, Inc. Is Off 10% in 2016, and This Is a Big Reason Why - The "Queen" has fallen, and so has PDL BioPharma's dividend.
06/20/16 07:21 AMPDL BioPharma, Inc. (NASDAQ:PDLI) Analyst Price Targets For The Coming Week - Fiscal Standard
06/18/16 09:09 AM2 Biotech Stocks That Could Raise Their Dividends -- and 1 That Won't - Gilead and Amgen look to be in great shape for increasing dividends. PDL BioPharma? Not so much.
06/16/16 09:58 AMBiotechnology Stocks on our Radar -- Array BioPharma, PDL BioPharma, Advaxis, and TetraLogic Pharma
06/13/16 03:09 PMPDL BioPharma Completes Quarterly Dividend Payment - [at noodls] - INCLINE VILLAGE, Nev., June 13, 2016 /PRNewswire/ -- PDL BioPharma, Inc. (PDL or the Company) (NASDAQ: PDLI) today announced that it has paid the June 13, 2016, quarterly dividend payment of $0.05 per ...
06/11/16 05:55 PMEarnings Overview of the Stocks: FuelCell Energy Inc. (NASDAQ:FCEL), PDL BioPharma, Inc. (NASDAQ:PDLI) - Beacon Chronicle
06/11/16 08:37 AMStocks inside Analysts Spotlight: Alkermes plc (NASDAQ:ALKS) , PDL BioPharma, Inc. (NASDAQ:PDLI) - Street Updates
06/09/16 06:09 PMPDL BioPharma, Inc. (NASDAQ:PDLI) Fundamental Star Rating Report - CML News
06/09/16 08:43 AMTraders Attention Alert: Biocept, Inc. (NASDAQ:BIOC) , PDL BioPharma, Inc. (NASDAQ:PDLI) - Street Updates
06/07/16 05:57 PMTake a look at Price Fluctuations: PDL BioPharma, Inc. (NASDAQ:PDLI) , Nektar Therapeutics (NASDAQ:NKTR) - Street Updates
06/07/16 05:57 PMNotable Earnings Analysis: Unit Corporation (NYSE:UNT), PDL BioPharma, Inc. (NASDAQ:PDLI) - Beacon Chronicle
06/06/16 09:26 AMPerformance Review for PDL BioPharma, Inc. (NASDAQ:PDLI) - HNN
06/06/16 09:26 AMNew Broker Ratings For PDL BioPharma, Inc. (NASDAQ:PDLI) - FTSE News
06/03/16 06:18 PMPrice Target Summary Report: Starwood Property Trust, Inc. (NYSE:STWD), PDL BioPharma, Inc. (NASDAQ:PDLI) - Beacon Chronicle
06/03/16 06:18 PMBiotech Movers: Mylan N.V. (NASDAQ:MYL) , PDL BioPharma, Inc. (NASDAQ:PDLI) - Is stories
06/03/16 03:14 PMPDL BIOPHARMA, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/03/16 08:39 AMPDL BioPharma Inc. (PDLI) is Trading Higher on Unusual Volume for June 01 - Equities.com - PDL BioPharma Inc. (PDLI) is Trading Higher on Unusual Volume for June 01Equities.comPDL BioPharma Inc. (PDLI) experienced unusually high volume on Jun. 01, as the stock gained 0.58% to a closing price of $3.46. The stock saw 2.98 million shares trade hands over the course of the day on 12,874 trades. Given that the stock's average ...PDL BioPharma Inc (PDLI) Raised to Hold at Zacks Investment ResearchLet Me Know About Thisall 2 news articles »
06/02/16 06:09 PMStock's Earnings Analysis Report: PDL BioPharma, Inc. (NASDAQ:PDLI), Weyerhaeuser Co. (NYSE:WY) - Beacon Chronicle - Beacon ChronicleStock's Earnings Analysis Report: PDL BioPharma, Inc. (NASDAQ:PDLI), Weyerhaeuser Co. (NYSE:WY)Beacon ChronicleLast Trade: The Company closed its last session at $31.32 with the loss of -0.57%. The market capitalization of the company is $23.23 Billion, with the average Volume of 5.33 Million. The stock currently has its 52-Week High range of $33.1 and 52-week ...and more »
06/02/16 11:37 AMPDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -
06/02/16 08:45 AMPDL BioPharma (NASDAQ:PDLI) & CombiMatrix Corp (NASDAQ:CBMX) Healthcare Stocks in the News - Wall Street 24 - PDL BioPharma (NASDAQ:PDLI) & CombiMatrix Corp (NASDAQ:CBMX) Healthcare Stocks in the NewsWall Street 24On Wednesday, Shares of PDL BioPharma Inc (NASDAQ:PDLI) lost -3.62% to $3.46. The share price is trading in a range of $3.35 – $3.56. The stock exchanged hands with 3.09 Million shares contrast to its average daily volume of 1.41 Million shares.and more »
06/01/16 06:16 PMPDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for June 02, 2016 - Nasdaq - PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for June 02, 2016NasdaqPDL BioPharma, Inc. ( PDLI ) will begin trading ex-dividend on June 02, 2016. A cash dividend payment of $0.05 per share is scheduled to be paid on June 13, 2016. Shareholders who purchased PDLI prior to the ex-dividend date are eligible for the cash ...PDL BioPharma, Inc. (NASDAQ:PDLI) Analyst ReviewRisers & FallersAre Analysts Bearish PDL BioPharma Inc (NASDAQ:PDLI) After Last Week?HNNTrending Biotech Stocks Update: Celator Pharmaceuticals Inc. (NASDAQ:CPXX) , PDL BioPharma, Inc. (NASDAQ:PDLI)Is storiesPR Newswire (press release) -Finance Dailyall 6 news articles »
06/01/16 08:40 AMPDL BioPharma Inc (PDLI) Jumps 7.49% on May 31 - Equities.com - Is storiesPDL BioPharma Inc (PDLI) Jumps 7.49% on May 31Equities.comPDL BioPharma Inc (PDLI) was among the biggest gainers on the Russell 2000 for Tuesday May 31 as the stock popped 7.49% to $3.59, representing a gain of $0.25 per share. Some 2.97 million shares traded hands on 11,467 trades, compared with an ...PDL BioPharma Inc (NASDAQ:PDLI) Stock Price Will Hit 3.75:AnalystCWRU ObserverPDL BioPharma, Inc. (NASDAQ:PDLI) Yearly Accrued Expenses At $120.87 MillionsEnterprise LeaderMoving Healthcare Focused Stocks: Relypsa, Inc. (NASDAQ:RLYP) , PDL BioPharma, Inc. (NASDAQ:PDLI)Is storiesShare Trading News -iStreetWire -The Postall 7 news articles »
06/01/16 06:13 AMPDL BioPharma to Present at the Jefferies 2016 Healthcare Conference - [at noodls] - INCLINE VILLAGE, Nev., June 1, 2016 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, the company's president and chief executive officer, will present at ...
05/31/16 09:35 AMStock's Earnings Analysis Report: Celator Pharmaceuticals (CPXX), PDL BioPharma (PDLI) - Beacon Chronicle - Beacon ChronicleStock's Earnings Analysis Report: Celator Pharmaceuticals (CPXX), PDL BioPharma (PDLI)Beacon ChroniclePDL BioPharma Inc (NASDAQ:PDLI) currently has High Price Target of $ 4.00. The Low and Mean Price Targets are $ 3.50 and $ 3.75 respectively. These price targets are a consensus analysis of 2 brokers. When having a look at Recommendation Trends of ...and more »
05/30/16 11:16 AMNext Weeks Broker Price Targets For PDL BioPharma, Inc. (NASDAQ:PDLI) - Share Trading News - Next Weeks Broker Price Targets For PDL BioPharma, Inc. (NASDAQ:PDLI)Share Trading NewsPDL BioPharma, Inc. has a 50 day moving average of 3.41 and a 200 day moving average of 3.38. The stock's market capitalization is 551.48M, it has a 52-week low of 2.58 and a 52-week high of 6.83. The share price of the company (NASDAQ:PDLI) was up ...Pdl Biopharma Incorporated (NASDAQ:PDLI) Short Interest Decreased By 5.04%The Postall 3 news articles »
05/27/16 10:41 AMInvestors Trading Alert: Oncothyreon Inc. (NASDAQ:ONTY) , PDL BioPharma, Inc. (NASDAQ:PDLI) - Street Updates - Investors Trading Alert: Oncothyreon Inc. (NASDAQ:ONTY) , PDL BioPharma, Inc. (NASDAQ:PDLI)Street UpdatesOn 5/26/2016, shares of Oncothyreon Inc. (NASDAQ:ONTY) fell -2.56% in trading session and finally closed at $1.14. The company most recent volume stood at 838.26 thousand shares as compared to its average volume of 938.28 thousand shares. Over the ...
05/26/16 05:24 AMHealthcare Stocks to Keep Your Eyes on: PDL BioPharma Inc (NASDAQ:PDLI), Aetna Inc (NYSE:AET) - NYSE Journal (press release) - Healthcare Stocks to Keep Your Eyes on: PDL BioPharma Inc (NASDAQ:PDLI), Aetna Inc (NYSE:AET)NYSE Journal (press release)On Wednesday, Shares of PDL BioPharma Inc (NASDAQ:PDLI), added 4.6% and closed at $3.33 in the last trading session. The last trading range of the stock ranges between $3.23 and $3.35. PDL BioPharma, Inc. (PDL) (PDLI) recently declared that PDL ...PDL BioPharma, Inc. (NASDAQ:PDLI) Quarterly EPS From Continuing Operations Stands At $0.3414Enterprise LeaderYesterday Stock's Trend Overview: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) , PDL BioPharma, Inc. (NASDAQ ...Street UpdatesPDL BioPharma, Inc. (NASDAQ:PDLI) Updated Broker RatingsRisers & FallersWall Street Hints and News -Seneca Globe -Sonoran Weekly Reviewall 18 news articles »
05/25/16 01:00 PMYesterday Stock's Trend Overview: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) , PDL BioPharma, Inc. (NASDAQ ... - Street Updates - 24/7 Wall St.Yesterday Stock's Trend Overview: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) , PDL BioPharma, Inc. (NASDAQ ...Street UpdatesPDL BioPharma, Inc. (NASDAQ:PDLI) after beginning at $3.18, closed at $3.20 by building up +1.59% in recent trading session. Most recent session's volume of 759.7 thousand shares lower than its average volume of 2.12 million shares. The company has ...PDL BioPharma, Inc. (NASDAQ:PDLI) Updated Broker RatingsRisers & FallersHow Analysts Feel About PDL BioPharma Inc (NASDAQ:PDLI)?Wall Street Hints and NewsPDL BioPharma to Acquire Novartis' Hypertension Drugs Via Majority Equity Investment in Noden Pharma (NASDAQ ...Sonoran Weekly ReviewEnterprise Leader -24/7 Wall St. -Zacks.comall 12 news articles »
05/25/16 09:02 AMPDL BioPharma Agrees to Equity Investment in Noden Pharma -
05/24/16 03:26 PMPDL BioPharma Commits to Equity Investment in Noden Pharma for the Acquisition of Tekturna® (aliskiren) and Tekturna HCT® (aliskiren and hydrochlorothiazide) - [at noodls] - INCLINE VILLAGE, Nev., May 24, 2016 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that PDL has committed to an equity investment in Noden Pharma DAC, a new privately held company ...
05/24/16 03:04 PM4:04 pm PDL BioPharma to make initial $107 mln equity investment in Noden Pharma, a new privately held co that has executed a purchase agreement with Novartis (NVS) -
05/24/16 01:24 PMPDL BioPharma, Inc. (NASDAQ:PDLI) Impact Score At 90 - Investor Newswire - PDL BioPharma, Inc. (NASDAQ:PDLI) Impact Score At 90Investor NewswireAlpha One explored various online articles released on PDL BioPharma, Inc. (NASDAQ:PDLI), and it set a daily sentiment score of 0.142 on the company. The entity has an algorithm in place to know stock sentiment on the share after exploring the content ...and more »
05/23/16 04:30 PMETF’s with exposure to PDL BioPharma, Inc. : May 23, 2016 -
05/21/16 12:44 PMPdl Biopharma Incorporated (NASDAQ:PDLI) Sellers Covered 1.25% of Their Shorts - Wall Street Hints and News - Pdl Biopharma Incorporated (NASDAQ:PDLI) Sellers Covered 1.25% of Their ShortsWall Street Hints and NewsThe short interest to Pdl Biopharma Incorporated's float is 8.61%. The stock increased 0.63% or $0.02 during the last trading session, hitting $3.17. About 697,312 shares traded hands. PDL BioPharma Inc (NASDAQ:PDLI) has declined 31.97% since October ...
05/20/16 01:11 PMHealthcare Stock Showing Performance: PDL BioPharma (PDLI) - News Oracle - Healthcare Stock Showing Performance: PDL BioPharma (PDLI)News OracleNow when we talk about Revenue Estimate for the current Fiscal Quarter, Average Revenue Estimate of PDL BioPharma Inc (NASDAQ:PDLI) is projected as $33.46 million where Low Revenue estimate and High Revenue Estimate are $27.20 Million and ...and more »
05/18/16 01:29 PMRevenue Update on PDL BioPharma Inc(NASDAQ:PDLI) - Trade Calls - News OracleRevenue Update on PDL BioPharma Inc(NASDAQ:PDLI)Trade CallsPDL BioPharma Inc(NASDAQ:PDLI) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during After-hours on May 4, 2016. Company reported revenue of $130.23M. Analysts estimated a revenue of $142.05M. Earnings per ...PDL BioPharma, Inc. (NASDAQ:PDLI) Updated Analyst CoverageRisers & FallersPDL BioPharma Inc (PDLI) Jumps 5.05% on May 16Equities.comBiotech Stocks Worth Chasing: PDL BioPharma, Inc. (PDLI), MannKind Corp. (MNKD)ZergwatchCWRU Observer -News Oracleall 6 news articles »
05/17/16 01:43 PMAverage EPS Report: PDL BioPharma Inc (NASDAQ:PDLI) - News Oracle - Average EPS Report: PDL BioPharma Inc (NASDAQ:PDLI)News OracleLast Trade: The Company fell -2.62% and finished at $2.97. The daily volume was measured at 1.60 million shares. The 52-week high of the share price is $6.83 and the 52-week low is $2.58. The company has a market cap of $477.53 million. The stock has a ...and more »
05/17/16 01:43 PMAlpha One Assigns Impact Score Of 33 To PDL BioPharma, Inc. (NASDAQ:PDLI) - Investor Newswire - Alpha One Assigns Impact Score Of 33 To PDL BioPharma, Inc. (NASDAQ:PDLI)Investor NewswireAlpha One analyzed the various web articles published on PDL BioPharma, Inc. (NASDAQ:PDLI), and thereafter it gave company a daily sentiment score of 0. The entity designs algorithm based assessment to known stock sentiment on stock after considering ...and more »
05/17/16 01:43 PMYesterday Healthcare Buzzers: Mylan N.V. (NASDAQ:MYL) , PDL BioPharma, Inc. (NASDAQ:PDLI) - Is stories - Is storiesYesterday Healthcare Buzzers: Mylan N.V. (NASDAQ:MYL) , PDL BioPharma, Inc. (NASDAQ:PDLI)Is storiesIn most recently trading session on 5/16/2016, PDL BioPharma, Inc. (NASDAQ:PDLI) climbed +5.05% while traded on 1.59 million shares versus it's an average volume of 2.24 million shares. The company recorded the last trade with the price of $3.12.and more »
05/13/16 07:20 AMStock's Earnings Analysis: PDL BioPharma Inc (NASDAQ:PDLI) - News Oracle - Stock's Earnings Analysis: PDL BioPharma Inc (NASDAQ:PDLI)News OracleLast Trade: The Company fell -2.46% and finished at $3.17. The daily volume was measured at 823,000.00 shares. The 52-week high of the share price is $6.83 and the 52-week low is $2.58. The company has a market cap of $525.03 million. The stock has a ...and more »
05/12/16 02:40 PMETF’s with exposure to PDL BioPharma, Inc. : May 12, 2016 -
05/12/16 07:33 AMPDL BioPharma (PDLI) Reports Amended Agreement with ARIAD (ARIA) - Claim your 2-week free trial to StreetInsider Premium here. PDL BioPharma (NASDAQ: PDLI) disclosed in an SEC filing: On July 28, 2015, PDL BioPharma, Inc. (the Company) entered into a Revenue Interests Assignment Agreement (the Royalty Agreement ...
05/11/16 05:02 AMPDL BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Ob -
05/10/16 11:43 AMPDL BioPharma, Inc. :PDLI-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/10/16 10:28 AMWhy PDL BioPharma, Inc.'s 13% Rally in April Probably Isn't Sustainable - The "Queen" has fallen, and so with it have PDL's profits and dividend.
05/10/16 07:04 AMPDL BioPharma, Inc. (NASDAQ:PDLI) Latest Impact Score At 90 - Investor Newswire - PDL BioPharma, Inc. (NASDAQ:PDLI) Latest Impact Score At 90Investor NewswirePDL BioPharma, Inc. (NASDAQ:PDLI) has a 0.56 daily sentiment score given by Alpha One after scanning articles on various online news platform. Alpha One performs algorithm based analysis to reach stock sentiment based on content published on ...and more »
05/08/16 06:45 AMQ1 Results: PDL BioPharma Inc (NASDAQ:PDLI) - share market updates (press release) - Q1 Results: PDL BioPharma Inc (NASDAQ:PDLI)share market updates (press release)Shares of PDL BioPharma Inc (NASDAQ:PDLI) ended Friday session in red amid volatile trading. The shares closed down -0.03 points or -0.94% at $3.17 with 1.21 million shares getting traded. Post opening the session at $3.16, the shares hit an intraday ...
04/04/16 04:31 PMUndervalued Companies With Growing EPS -
About PDL BioPharma

PDL BioPharma logoPDL BioPharma, Inc., manages a portfolio of patents and royalty assets, consisting of its Queen et al. patents, license agreements with various biotechnology and pharmaceutical companies, and royalty and other assets acquired. The Company provides non-dilutive growth capital and financing solutions to late-stage public and private healthcare companies and offers immediate financial monetization of royalty streams to companies, academic institutions, and inventors. It is focused on intellectual property asset management, acquiring new income generating assets and maximizing value for its stockholders. The Company receives royalties on a number of marketed products that use its technology and it has liscensed a number of humanized antibody products in late-stage clinical trials. As of December 31, 2014, the Company received royalties on sales of the ten humanized antibody products, which include Avastin, Herceptin, Xolair, Lucentis, Perjeta, Kadcyla, Tysabri, Actemra, Gazyva and Entyvio.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: PDLI
  • CUSIP: 69329Y10
Key Metrics:
  • Previous Close: $3.14
  • 50 Day Moving Average: $3.22
  • 200 Day Moving Average: $3.30
  • P/E Ratio: 1.70
  • P/E Growth: 0.50
  • Market Cap: $518.46M
  • Current Quarter EPS Consensus Estimate: $0.45 EPS
Additional Links:
PDL BioPharma (NASDAQ:PDLI) Chart for Friday, June, 24, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha